Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
500
Employees500
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
500
Employees500

CORT Key Statistics

Market cap
7.35B
Market cap7.35B
Price-Earnings ratio
61.92
Price-Earnings ratio61.92
Dividend yield
Dividend yield
Average volume
656.75K
Average volume656.75K
High today
$69.88
High today$69.88
Low today
$68.82
Low today$68.82
Open price
$69.48
Open price$69.48
Volume
396.01K
Volume396.01K
52 Week high
$117.33
52 Week high$117.33
52 Week low
$33.34
52 Week low$33.34

CORT News

TipRanks 2d
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension

Corcept Therapeutics ((CORT)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

TipRanks 3d
Top Executive Sells Thousands in Corcept Therapeutics Stock!

New insider activity at Corcept Therapeutics ( (CORT) ) has taken place on August 26, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.